Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash from Investing (Quarterly): 10.08M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 10.08M |
June 30, 2023 | -51.94M |
March 31, 2023 | -15.76M |
December 31, 2022 | -11.13M |
September 30, 2022 | -12.30M |
June 30, 2022 | -3.161M |
Date | Value |
---|---|
March 31, 2022 | -90.70M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-90.70M
Minimum
Mar 2022
10.08M
Maximum
Sep 2023
-15.90M
Average
-3.161M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
Karuna Therapeutics Inc (DELISTED) | 92.44M |
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.00 |
Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -11.03M |
Free Cash Flow | -49.70M |
Free Cash Flow Per Share (Quarterly) | -0.2529 |